Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01678 | 34657611 | Lipids Health Dis | Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. | 2021 | Details |
| A01751 | 34629064 | Lipids Health Dis | Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan. | 2021 | Details |
| A01756 | 34628383 | Georgian Med News | THE INFLUENCE OF HYPERCHOLESTEROLEMIA AND CONCOMITANT STATIN THERAPY ON THE STATE OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A01760 | 34627696 | Nutr Metab Cardiovasc Dis | Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study. | 2021 | Details |
| A01761 | 34627692 | Nutr Metab Cardiovasc Dis | Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. | 2021 | Details |
| A01773 | 34622006 | JGH Open | Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score. | 2021 | Details |
| A01782 | 34619105 | Lancet Diabetes Endocrinol | COVID-19 and metabolic disease: mechanisms and clinical management. | 2021 | Details |
| A01789 | 34617207 | Obes Surg | Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus. | 2021 | Details |
| A01807 | 34607492 | Angiology | Pancretic Fat Accummulation is Associated with Subclinical Atherosclerosis. | 2021 | Details |
| A01813 | 34606912 | J Hepatol | Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it? | 2021 | Details |
| A01818 | 34604973 | Eur Rev Med Pharmacol Sci | Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. | 2021 | Details |
| A01860 | 34585892 | J Assoc Physicians India | Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India. | 2021 | Details |
| A01863 | 34584580 | Prz Gastroenterol | Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis. | 2021 | Details |
| A01904 | 34565785 | Korean J Gastroenterol | Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01933 | 34558853 | Hepatol Commun | Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection. | 2021 | Details |
| A01961 | 34552561 | Front Endocrinol (Lausanne) | GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH. | 2021 | Details |
| A01968 | 34548787 | Clin Interv Aging | NAFLD in the Elderly. | 2021 | Details |
| A01976 | 34544714 | BMJ Case Rep | Hepatopulmonary syndrome as the first and only manifestation of cirrhosis in a patient with hypopituitarism. | 2021 | Details |
| A01979 | 34543610 | Lancet | Liver cirrhosis. | 2021 | Details |
| A02015 | 34530527 | Clin Mol Hepatol | Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. | 2021 | Details |
| A02027 | 34527094 | Gastroenterology Res | Non-Invasive Assessment of Liver Fibrosis and Steatosis in End-Stage Renal Disease Patients Undergoing Renal Transplant Evaluation. | 2021 | Details |
| A02096 | 34508671 | Lancet Gastroenterol Hepatol | Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02099 | 34508436 | JNMA J Nepal Med Assoc | Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. | 2021 | Details |
| A02121 | 34498502 | Ann Med | High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China. | 2021 | Details |
| A02125 | 34497507 | Front Aging Neurosci | Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology. | 2021 | Details |
| A02129 | 34496264 | J Ethnopharmacol | Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. | 2021 | Details |
| A02146 | 34486981 | Endocr Connect | Nonalcoholic steatohepatitis: global impact and clinical consequences. | 2021 | Details |
| A02154 | 34484546 | Radiol Case Rep | Balloon-occluded antegrade transvenous obliteration of rectal varices: A case report. | 2021 | Details |
| A02155 | 34484304 | Front Genet | Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A02173 | 34475033 | Diabetes Care | Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC). | 2021 | Details |
| A02180 | 34472680 | Diabetes Obes Metab | Associations of weight loss with obesity-related comorbidities in a large integrated health system. | 2021 | Details |
| A02228 | 34453359 | Hepatology | Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. | 2021 | Details |
| A02265 | 34443333 | Molecules | Phenolics-Rich Extracts of Dietary Plants as Regulators of Fructose Uptake in Caco-2 Cells via GLUT5 Involvement. | 2021 | Details |
| A02267 | 34441497 | Foods | Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. | 2021 | Details |
| A02268 | 34441028 | Medicina (Kaunas) | Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. | 2021 | Details |
| A02319 | 34421816 | Front Endocrinol (Lausanne) | Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A02330 | 34416040 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. | 2021 | Details |
| A02363 | 34402473 | Eur J Gastroenterol Hepatol | Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression. | 2021 | Details |
| A02367 | 34400897 | Int J Med Sci | Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes. | 2021 | Details |
| A02385 | 34394332 | PPAR Res | Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases. | 2021 | Details |
| A02401 | 34386600 | JGH Open | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. | 2021 | Details |
| A02464 | 34362281 | Scand J Gastroenterol | Negative interaction of fatty liver and hypertension on cardiovascular mortality in non-diabetic men: 34 years of follow-up. | 2021 | Details |
| A02473 | 34360607 | Int J Mol Sci | Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD. | 2021 | Details |
| A02482 | 34358793 | Curr Opin Pharmacol | Very-low-calorie ketogenic diet: An alternative to a pharmacological approach to improve glycometabolic and gonadal profile in men with obesity. | 2021 | Details |
| A02491 | 34355155 | JHEP Rep | A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. | 2021 | Details |
| A02492 | 34354193 | Sci Rep | Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A02519 | 34342335 | Ann Acad Med Singap | New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore. | 2021 | Details |
| A02527 | 34340957 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2021 | Details |
| A02535 | 34337376 | Metabol Open | The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A02543 | 34333790 | Hepatology | A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis. | 2021 | Details |
| A02558 | 34328446 | Am J Gastroenterol | The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016. | 2021 | Details |
| A02561 | 34328120 | Biomed Pharmacother | Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells. | 2021 | Details |
| A02579 | 34324263 | Diabetes Obes Metab | Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. | 2021 | Details |
| A02613 | 34309833 | Eur J Clin Invest | Is there an 'ideal' diet for patients with NAFLD? | 2021 | Details |
| A02656 | 34295987 | Clin Exp Hepatol | Correlation of endoscopic findings with Doppler ultrasound in portal hypertension in children. | 2021 | Details |
| A02671 | 34290096 | Sci Adv | Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. | 2021 | Details |
| A02699 | 34278728 | Physiol Rep | Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study. | 2021 | Details |
| A02730 | 34269534 | Korean J Radiol | Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity. | 2021 | Details |
| A02731 | 34269508 | J Clin Hypertens (Greenwich) | Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. | 2021 | Details |
| A02737 | 34265276 | Lancet Gastroenterol Hepatol | Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. | 2021 | Details |
| A02753 | 34259033 | J Am Heart Assoc | Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects. | 2021 | Details |
| A02785 | 34242466 | Liver Int | Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis. | 2021 | Details |
| A02861 | 34213749 | Indian J Gastroenterol | Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. | 2021 | Details |
| A02868 | 34211711 | SAGE Open Med | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | 2021 | Details |
| A02883 | 34206404 | Int J Mol Sci | Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches. | 2021 | Details |
| A02917 | 34199258 | J Clin Med | The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter. | 2021 | Details |
| A02938 | 34190778 | Arq Gastroenterol | EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A02942 | 34190160 | Medicine (Baltimore) | A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease. | 2021 | Details |
| A02985 | 34174011 | Liver Int | Ultra-processed food is associated with features of metabolic syndrome and non-alcoholic fatty liver disease. | 2021 | Details |
| A02990 | 34171957 | Vnitr Lek | The use of moxonidine in the treatment of arterial hypertension. | 2021 | Details |
| A02993 | 34171462 | Biochim Biophys Acta Gene Regul Mech | Polymorphisms rs55710213 and rs56334587 regulate SCD1 expression by modulating HNF4A binding. | 2021 | Details |
| A03022 | 34160360 | Turk J Gastroenterol | The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade. | 2021 | Details |
| A03047 | 34154037 | J Gastroenterol Hepatol | Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. | 2021 | Details |
| A03066 | 34145341 | Sci Rep | High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. | 2021 | Details |
| A03101 | 34130852 | Semin Ultrasound CT MR | What's New in Hepatic Steatosis. | 2021 | Details |
| A03113 | 34125886 | J Clin Endocrinol Metab | New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease. | 2021 | Details |
| A03172 | 34103552 | Sci Rep | Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. | 2021 | Details |
| A03184 | 34096467 | Bioengineered | The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. | 2021 | Details |
| A03186 | 34095739 | J Pancreat Cancer | Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis. | 2021 | Details |
| A03202 | 34091530 | Chin Med J (Engl) | Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016. | 2021 | Details |
| A03215 | 34087329 | Adv Drug Deliv Rev | Role of extracellular vesicles in liver diseases and their therapeutic potential. | 2021 | Details |
| A03224 | 34081733 | PLoS One | Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. | 2021 | Details |
| A03225 | 34081362 | J Intern Med | Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients. | 2021 | Details |
| A03228 | 34080327 | J Cachexia Sarcopenia Muscle | Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey. | 2021 | Details |
| A03270 | 34065140 | Children (Basel) | Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. | 2021 | Details |
| A03277 | 34064337 | J Clin Med | Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. | 2021 | Details |
| A03289 | 34059612 | Curr Opin Cardiol | Update on cardiovascular risk in nonalcoholic fatty liver disease. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03356 | 34030288 | Sci Total Environ | Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: A population-based study. | 2021 | Details |
| A03359 | 34028830 | Med J Aust | Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. | 2021 | Details |
| A03376 | 34025577 | Front Endocrinol (Lausanne) | Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. | 2021 | Details |
| A03381 | 34023517 | Spine J | Cardiovascular and metabolic morbidity following spinal cord injury. | 2021 | Details |
| A03404 | 34014280 | Dis Model Mech | Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. | 2021 | Details |
| A03405 | 34014044 | Pharmacol Res Perspect | Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision-cut liver slices. | 2021 | Details |
| A03437 | 34001005 | BMC Gastroenterol | Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study. | 2021 | Details |
| A03482 | 33987427 | Ann Transl Med | Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03503 | 33979961 | Zhonghua Gan Zang Bing Za Zhi | [Higher proportion of hepatitis B-related hepatocellular carcinoma combined with metabolic diseases in patients receiving antiviral therapy]. | 2021 | Details |
| A03529 | 33967554 | World J Gastroenterol | Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. | 2021 | Details |
| A03552 | 33960110 | Obes Rev | Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat-A systematic review and meta-analysis. | 2021 | Details |